Imagine a career in a field you can’t imagine. Dominique Constantini parlayed her commitment to immunology to meeting unmet ...

ALX Oncology Holdings Inc. (NASDAQ:ALXO), a biopharmaceutical company currently valued at $93.36 million, has announced the adoption of a new equity incentive plan, effective January 16, 2025. The ...

Prostate cancer presents challenges in detection, treatment, and management. Learn about genetic risks, treatment resistance, ...

Elevation Oncology Inc (ELEV) stock saw a decline, ending the day at $0.73 which represents a decrease of $-0.05 or -6.41% from the prior close of $0.78. The stock opened at $0.78 and touched a low of ...

Oklahoma Cancer Specialists and Research Institute has partnered with a non-profit oncology research organization, granting ...

Patients of European ancestry are more likely to find a match to the latest targeted cancer drugs than patients of other ...

Predictive Oncology Inc. (NASDAQ: NASDAQ:POAI), a company specializing in artificial intelligence (AI)-driven drug discovery with a current market capitalization of $7.93 million, announced its ...

The one-and-a-half-day symposium provides an overview of recent advances in the treatment of solid tumors with novel targeted ...

The Perlmutter Cancer Center at New York City-based NYU Langone Health recently launched its new Center for Molecular Oncology, naming Shridar Ganesan, MD, PhD, as director. The center will manage, ...

Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery, today announced plans to launch its validated ...

In this second half of our interview with Vanderbilt University Medical Center’s Travis Osterman, DO, MS, FAMIA, FASCO, he ...

Combination creates immediate scientific synergies by harnessing complementary AI / ML platforms to improve patient outcomes across multiple ...